Virax Biolabs Group Limit...
(VRAX)
undefined
undefined%
At close: undefined
2.39
-2.05%
After-hours Jan 03, 2025, 05:56 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 |
| Revenue | 156.42K | 8.56K | n/a | 123.82K | 99.88K |
| Cost of Revenue | 105.83K | 9.93K | n/a | 133.25K | 54.13K |
| Gross Profit | 50.59K | -1.36K | n/a | -9.43K | 45.75K |
| Operating Income | -6.50M | -5.73M | -1.73M | -644.54K | -651.24K |
| Interest Income | n/a | 15.47K | 15.44K | 28.64K | 90.69K |
| Pretax Income | -6.74M | -5.46M | -1.75M | -672.91K | -739.46K |
| Net Income | -6.73M | -5.46M | -1.71M | -650.98K | -801.13K |
| Selling & General & Admin | 4.59M | 5.33M | 1.30M | 514.88K | 609.99K |
| Research & Development | 1.56M | 397.11K | 433.74K | 120.22K | 87.00K |
| Other Expenses | 390.36K | 290.47K | n/a | 266.00 | 2.47K |
| Operating Expenses | 6.55M | 5.73M | 1.73M | 635.10K | 696.99K |
| Interest Expense | 26.88K | 15.47K | 15.44K | 28.64K | 90.69K |
| Selling & Marketing Expenses | n/a | 26.62K | 13.82K | 57.20K | 7.69K |
| Cost & Expenses | 6.65M | 5.74M | 1.73M | 768.36K | 751.12K |
| Income Tax | n/a | -271 | -1.77M | -666.47K | 61.67K |
| Shares Outstanding (Basic) | 2.01M | 1.06M | 1.14M | 1.14M | 1.14M |
| Shares Outstanding (Diluted) | 2.01M | 1.06M | 1.14M | 1.14M | 1.14M |
| EPS (Basic) | -3.36 | -5.13 | -1.5 | -0.57 | -0.7 |
| EPS (Diluted) | -3.36 | -5.13 | -1.5 | -0.57 | -0.7 |
| EBITDA | -6.61M | -5.44M | -750 | n/a | -648.77K |
| Depreciation & Amortization | 103.10K | 1.00 | 1.73M | 644.54K | 651.24K |